Kynurenines in the mammalian brain: when physiology meets pathology

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898

Mammalian nicotinic acetylcholine receptors: from structure to function

Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682

Microglia in neurodegenerative disease

Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

Coyle, J. T., & Schwarcz, R. M. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,255

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

Lahti, A., Koffel, B., Laporte, D., & Tamminga, C. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 965

Neuropharmacology of quinolinic and kynurenic acids.

Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 949

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Hilmas, C. J., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R. M., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 875

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid

Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849

Autism‐like behavioral phenotypes in BTBR T+tf/J mice

McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812

Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

Fukui, S., Schwarcz, R. M., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 765

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751

Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35

Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J. D., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 708

QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE

Heyes, M. P., Saito, K., Crowley, J. S., DAVIS, L. E., Demitrack, M. A., Der, M. G., Dilling, L. A., Elia, J., Kruesi, M. J. P., Lackner, A. A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 684

Hypoglycemia-Induced Neuronal Damage Prevented by an N -Methyl-D-Aspartate Antagonist

Wieloch, T. W. (1985) · Science · doi:10.1126/science.2996146 · Cited by 670

Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling

DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 651

Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 642

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630

Increased cortical kynurenate content in schizophrenia

Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Pilotte, L., Larrieu, P., Stroobant, V., Colau, D., Dolušić, E., Frédérick, R., Plaen, E. D., Uyttenhove, C., Wouters, J., Masereel, B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113873109 · Cited by 582

Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

Steiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568

Elaborate interactions between the immune and nervous systems

Steinman, L. (2004) · Nature Immunology · doi:10.1038/ni1078 · Cited by 556

Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

Schwarcz, R. M., & Pellicciari, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru‐Lamoury, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 541

Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions

Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., Day, T. A., & Walker, F. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.02.001 · Cited by 531

Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guérin

O’Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 521

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

Zwilling, D., Huang, S., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H., Lee, J. H., Truong, J. K., Andrews-Zwilling, Y. S., Hsieh, E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 519

Interferon-alpha–induced changes in tryptophan metabolism

Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L., & Engberg, G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02242-x · Cited by 478

3‐Hydroxykynurenine, an Endogenous Oxidative Stress Generator, Causes Neuronal Cell Death with Apoptotic Features and Region Selectivity

Okuda, S., Nishiyama, N., Saitō, H., & Katsuki, H. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010299.x · Cited by 465

Human macrophages convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 451

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Wang, Y., Liu, H., McKenzie, G. A., Witting, P. K., Stasch, J., Hahn, M. G., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446

II: Excitotoxic models for neurodegenerative disorders

Schwarcz, R., Foster, A., French, E., Whetsell, W., & Köhler, C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90148-6 · Cited by 442

Microglial activation in presymptomatic Huntington's disease gene carriers

Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

Foster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. M. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 435

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434

Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis

Zunszain, P. A., Anacker, C., Cattaneo, A., Choudhury, S., Musaelyan, K., Myint, A. M., Thuret, S., Price, J., & Pariante, C. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.277 · Cited by 388

Glutamate-based antidepressants: 20 years on

Skolnick, P., Popik, P., & Trullás, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.002 · Cited by 386

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 350

On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress

Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., et al. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2011.07.002 · Cited by 346

Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.

Christen, S., Peterhans, E., & Stocker, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2506 · Cited by 341

Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus

Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 338

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

Linderholm, K., Skogh, E., Olsson, S., Dahl, M., Holtze, M., Engberg, G., Samuelsson, M., & Erhardt, S. (2012) · Schizophrenia bulletin · doi:10.1093/schbul/sbq086 · Cited by 335

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005) · Nature Genetics · doi:10.1038/ng1542 · Cited by 331

Characterization of the Kynurenine Pathway in Human Neurons

Guillemin, G. J., Cullen, K. M., Lim, C. K., Smythe, G. A., Garner, B., Kapoor, V., Takikawa, O., & Brew, B. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4101-07.2007 · Cited by 331

Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

Birch, P., Grossman, C., & Hayes, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90367-6 · Cited by 324

l-Kynurenine Its synthesis and possible regulatory function in brain

G�l, E. M., & Sherman, A. D. (1980) · Neurochemical Research · doi:10.1007/bf00964611 · Cited by 318

Kynurenine pathway abnormalities in Parkinson's disease

Ogawa, T., Matson, W. R., Beal, M. F., Myers, R. H., Bird, E. D., Milbury, P. E., & Saso, S. (1992) · Neurology · doi:10.1212/wnl.42.9.1702 · Cited by 317

Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders

Goto, Y., Yang, C. R., & Otani, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.026 · Cited by 316

Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal

Hanson, N. D., Owens, M. J., & Nemeroff, C. B. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.220 · Cited by 311

Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies

Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., & Iosifescu, D. V. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.06.006 · Cited by 307

Induction of IDO by Bacille Calmette-Guérin Is Responsible for Development of Murine Depressive-Like Behavior

O’Connor, J. C., Lawson, M. A., André, C., Briley, E. M., Szegedi, S. S., Lestage, J., Castanon, N., Herkenham, M. A., Dantzer, R., & Kelley, K. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802722 · Cited by 305

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase.

Cady, S. G., & Sono, M. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90142-6 · Cited by 298

Presence of Kynurenic Acid in the Mammalian Brain

Moroni, F., Russi, P., Lombardi, G., Beni, M. H. H., & Carla�, V. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04852.x · Cited by 279

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

Baban, B., Chandler, P., McCool, D. J., Marshall, B., Munn, D. H., & Mellor, A. L. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2003.11.003 · Cited by 277

Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice

Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., & Nakamura, T. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-8 · Cited by 276

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway

Ball, H. J., Yuasa, H. J., Austin, C., Weiser, S., & Hunt, N. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.005 · Cited by 275

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

Rı́os, C., & Santamarı́a, A. (1991) · Neurochemical Research · doi:10.1007/bf00966592 · Cited by 272

Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression

Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., & Rajkowska, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300525 · Cited by 268

The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease

Campesan, S., Green, E. W., Breda, C., Sathyasaikumar, K. V., Muchowski, P. J., Schwarcz, R. M., Kyriacou, C. P., & Giorgini, F. (2011) · Current Biology · doi:10.1016/j.cub.2011.04.028 · Cited by 261

Human microglia convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Achim, C. L., Wiley, C. A., Major, E. O., Saito, K., & Markey, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260

Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors

Swartz, K., During, M. J., Freese, A. B., & Beal, M. F. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-09-02965.1990 · Cited by 259

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

GUIDETTI, P., Luthi‐Carter, R., Augood, S. J., & Schwarcz, R. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 259

The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

Rahman, A., Ting, K., Cullen, K. M., Braidy, N., Brew, B. J., & Guillemin, G. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006344 · Cited by 257

Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia

Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253

Structure, expression, and function of kynurenine aminotransferases in human and rodent brains

Han, Q., Cai, T., Tagle, D. A., & Li, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0166-4 · Cited by 246

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

Miller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 243

Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior

Potter, M., Elmer, G., Bergeron, R., Albuquerque, E. X., Guidetti, P., Wu, H., & Schwarcz, R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.39 · Cited by 235

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

Miller, C. L., Llenos, I. C., Dulay, J. R., Barillo, M. M., Yolken, R. H., & Weis, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.015 · Cited by 232

Expression of The Kynurenine Pathway Enzymes in Human Microglia and Macrophages

Guillemin, G. J., Smith, D. G., Smythe, G. A., Armati, P. J., & Brew, G. J. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0135-0_12 · Cited by 229

Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis

Sakurai, K., Zou, J.-P., Tschetter, J. R., Ward, J. M., & Shearer, G. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00176-5 · Cited by 229

Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory Deficits

Chess, A. C., Simoni, M. K., Alling, T. E., & Bucci, D. J. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl033 · Cited by 227

Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ?

Connor, T. J., Starr, N., O’Sullivan, J. B., & Harkin, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.007 · Cited by 222

Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model

Yue, E. W., Douty, B. D., Wayland, B. R., Bower, M. J., Liu, X., Leffet, L., Wang, Q., Bowman, K., Hansbury, M., Liu, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900518f · Cited by 221

Identification and quantification of kynurenic acid in human brain tissue

Turski, W. A., Nakamura, M., Todd, W. P., Carpenter, B. K., Whetsell, W. O., & Schwarcz, R. M. (1988) · Brain Research · doi:10.1016/0006-8993(88)90815-3 · Cited by 220

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

Beal, M. F., Matson, W. R., Storey, E., Milbury, P. E., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 220

Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway

Thomas, S. R., & Stocker, R. (1999) · Redox Report · doi:10.1179/135100099101534927 · Cited by 215

Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery

Moroni, F., Cozzi, A., Sili, M., & Mannaioni, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0763-x · Cited by 213

Synthesis and Biochemical Evaluation ofN-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase

Röver, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 212

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 212

3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Generate Hydrogen Peroxide and Promote α-Crystallin Cross-Linking by Metal Ion Reduction

Goldstein, L. E., Leopold, M. C., Huang, X., Atwood, C., Saunders, A. J., Hartshorn, M. A., Lim, J. T., Faget, K. Y., Muffat, J., Scarpa, R. C., et al. (2000) · Biochemistry · doi:10.1021/bi992997s · Cited by 212

Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.

Parsons, C., Danysz, W., Quack, G. ̈., Hartmann, S., Lorenz, B., Wollenburg, C., Baran, L., Przegaliński, E., Kostowski, W., Krza̧ścik, P., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37160-5 · Cited by 207

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

Maes, M. H. J., Verkerk, R. M., Bonaccorso, S., Ombelet, W. U. A. M., Bosmans, E., & Scharpé, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01853-2 · Cited by 203

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.

Saito, K., Markey, S., & Heyes, M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90467-g · Cited by 196

Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice

Lapin, I. P. (1978) · Journal of Neural Transmission · doi:10.1007/bf01262727 · Cited by 193

Endogenous kynurenic acid disrupts prepulse inhibition.

Erhardt, S., Schwieler, L., Emanuelsson, C., & Geyer, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.006 · Cited by 187

Regulation of the Kynurenine Metabolic Pathway by Interferon‐γ in Murine Cloned Macrophages and Microglial Cells

Alberati‐Giani, D., Ricciardi‐Castagnoli, P., Köhler, C., & Cesura, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030996.x · Cited by 187

Kynurenine Pathway Enzymes in Dendritic Cells Initiate Tolerogenesis in the Absence of Functional IDO

Belladonna, M. L., Grohmann, U., Guidetti, P., Volpi, C., Bianchi, R., Fioretti, M. C., Schwarcz, R. M., Fallarino, F., & Puccetti, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.130 · Cited by 184

3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

Guidetti, P., & Schwarcz, R. M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180

Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system

Whetsell, W. O., & Schwarcz, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90609-5 · Cited by 176

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

Rassoulpour, A., Wu, H., Ferré, S., & Schwarcz, R. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174

Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

Pocivavsek, A., Wu, H., Potter, M. C., Elmer, G. I., Pellicciari, R., & Schwarcz, R. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.127 · Cited by 171

Quantitative aspects of tryptophan metabolism in humans and other species: a review.

Leklem, J. (1971) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/24.6.659 · Cited by 169

Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes

Wonodi, I., Stine, O. C., Sathyasaikumar, K. V., Roberts, R. C., Mitchell, B. D., Hong, L. E., Kajii, Y., Thaker, G. K., & Schwarcz, R. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.71 · Cited by 168

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice

Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E., Wheeler, V. C., Woodman, B., & Schwarcz, R. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166

Mitochondrial aspartate aminotransferase: a third kynurenate‐producing enzyme in the mammalian brain

Guidetti, P., Amori, L., Sapko, M. T., Okuno, E., & Schwarcz, R. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04556.x · Cited by 166

Mechanism of Delayed Increases in Kynurenine Pathway Metabolism in Damaged Brain Regions Following Transient Cerebral Ischemia

Saito, K., Nowak, T. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05836.x · Cited by 164

Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with ( m -Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol-2YL]-Benzenesulfonamide (Ro 61-8048) in Models of Focal or Global Brain Ischemia

Cozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 160

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carla�, V., Pellicciari, R., Mattoli, L., & Moroni, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90227-5 · Cited by 159

Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry

Guidetti, P., Hoffman, G. E., Meléndez‐Ferro, M., Albuquerque, E. X., & Schwarcz, R. M. (2006) · Glia · doi:10.1002/glia.20432 · Cited by 156

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

Pearson, S. J., & Reynolds, G. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90749-w · Cited by 155

On the relationship between the two branches of the kynurenine pathway in the rat brainin vivo

Amori, L., Guidetti, P., Pellicciari, R., Kajii, Y., & Schwarcz, R. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05893.x · Cited by 154

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

Alexander, K., Wu, H., Schwarcz, R. M., & Bruno, J. P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2539-2 · Cited by 147

The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

Wu, H., Pereira, E. F. R., Bruno, J. P., Pellicciari, R., Albuquerque, E. X., & Schwarcz, R. M. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9235-2 · Cited by 146

THE ENDOGENEOUS AGONIST QUINOLINIC ACID AND THE NON ENDOGENOUS HOMOQUINOLINIC ACID DISCRIMINATE BETWEEN NMDAR2 RECEPTOR SUBUNITS

de Carvalho, L. P., Bochet, P., & Rossier, J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00091-7 · Cited by 145

The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes

Salter, M., & Pogson, C. I. (1985) · Biochemical Journal · doi:10.1042/bj2290499 · Cited by 137

Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease

Sapko, M. T., Guidetti, P., Yü, P., Tagle, D. A., Pellicciari, R., & Schwarcz, R. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.004 · Cited by 134

Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex

Kerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

Shepard, P. D., Joy, B., Prendeville, L. C., & Schwarcz, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300188 · Cited by 131

Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders

Oxenkrug, G. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0475-7 · Cited by 127

Synthesis of Quinolinic Acid by 3‐Hydroxyanthranilic Acid Oxygenase in Rat Brain Tissue In Vitro

Foster, A. C., White, R. J., & Schwarcz, R. M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb02826.x · Cited by 126

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

Bonda, D., Mailankot, M., Stone, J. G., Garrett, M. R., Staniszewska, M. M., Castellani, R. J., Siedlak, S. L., Zhu, X., Lee, H., Perry, G. L., et al. (2010) · Redox Report · doi:10.1179/174329210x12650506623645 · Cited by 126

Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release

Zmarowski, A., Wu, H., Brooks, J. M., Potter, M. C., Pellicciari, R., Schwarcz, R. M., & Bruno, J. P. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06594.x · Cited by 121

Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depression

Laugeray, A., Launay, J., Callebert, J., Surget, A., Belzung, C., & Barone, P. R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.014 · Cited by 117

Kynurenine Pathway Enzymes in Brain: Responses to Ischemic Brain Injury Versus Systemic Immune Activation

Saito, K., Nowak, T. S., Suyama, K., Quearry, B. J., Saito, M., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07443.x · Cited by 116

Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.

Foster, A., Miller, L., Oldendorf, W., & Schwarcz, R. (1984) · Experimental Neurology · doi:10.1016/0014-4886(84)90239-5 · Cited by 114

L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning

Chess, A. C., Landers, A., & Bucci, D. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.013 · Cited by 113

Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity

Owe‐Young, R., Webster, N. L., Mukhtār, M., Pomerantz, R. J., Smythe, G. A., Walker, D. W., Armati, P. J., Crowe, S. M., & Brew, B. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05241.x · Cited by 112

Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege

Huang, L., Baban, B., Johnson, B. A., & Mellor, A. L. (2010) · International Reviews of Immunology · doi:10.3109/08830180903349669 · Cited by 111

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis

Guillemin, G. J., Smith, D. G., Kerr, S. J., Smythe, G. A., Kapoor, V., Armati, P. J., & Brew, B. J. (2000) · Redox Report · doi:10.1179/135100000101535375 · Cited by 108

Similarities and differences in the neuronal death processes activated by 3OH‐kynurenine and quinolinic acid

Chiarugi, A., Meli, E., & Moroni, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00335.x · Cited by 107

Uptake of Kynurenine into Rat Brain Slices

Speciale, C., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13296.x · Cited by 106

Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder

Olsson, S. K., Samuelsson, M., Saetre, P., Lindström, L., Jönsson, E. G., Nordin, C., Engberg, G., Erhardt, S., & Landén, M. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090180 · Cited by 106

PRE- AND POSTNATAL EXPOSURE TO KYNURENINE CAUSES COGNITIVE DEFICITS IN ADULTHOOD

Pocivavsek, A., Wu, H., Elmer, G. I., Bruno, J. P., & Schwarcz, R. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08064.x · Cited by 105

Brain‐Specific Modulation of Kynurenic Acid Synthesis in the Rat

Gramsbergen, J. B., Hodgkins, P., Rassoulpour, A., Turski, W. A., Guidetti, P., & Schwarcz, R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010290.x · Cited by 105

Comparison of the Neurochemical and Behavioral Effects Resulting from the Inhibition of Kynurenine Hydroxylase and/or Kynureninase

Chiarugi, A., Carpenedo, R., Molina, M. T., Mattoli, L., Pellicciari, R., & Moroni, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031176.x · Cited by 105

(R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats

Speciale, C., Wu, H., Cini, M., Marconi, M., Varasi, M., & Schwarcz, R. M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00613-9 · Cited by 104

Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats

Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05540.x · Cited by 103

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum

Amori, L., Wu, H., Marinozzi, M., Pellicciari, R., Guidetti, P., & Schwarcz, R. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.055 · Cited by 101

Quinolinic acid — Iron(II) complexes: Slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction

Plátenı́k, J., Stopka, P., Vejražka, M., & Štípek, S. (2001) · Free Radical Research · doi:10.1080/10715760100300391 · Cited by 100

Kynurenines, Parkinson’s disease and other neurodegenerative disorders: preclinical and clinical studies

Németh, H., Toldi, J., & Vécsei, L. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_45 · Cited by 99

Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases

Prendergast, G. C., Chang, M. Y., Mandik‐Nayak, L., Metz, R. A., & Muller, A. J. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656072 · Cited by 98

Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment

Giorgini, F., Möller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S. Y., Tsai, L. L., Cheah, C. S., Schwarcz, R. M., Guidetti, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708192200 · Cited by 97

Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model

Guidetti, P., Reddy, P. H., Tagle, D. A., & Schwarcz, R. M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00956-3 · Cited by 97

The effect of quinolinate on rat brain lipid peroxidation is dependent on iron

Štípek, S., Šťastný, F., Plátenı́k, J., Crkovska, J., & Zima, T. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(97)90002-4 · Cited by 97

Electrochemical and in vitro evaluation of the redox-properties of kynurenine species

Giles, G. I., Collins, C. A., Stone, T. W., & Jacob, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02917-0 · Cited by 96

Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition

Clark, C. J., Mackay, G., Smythe, G. A., Bustamante, S., Stone, T. W., & PHILLIPS, R. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5249-5251.2005 · Cited by 96

Metabolism of [5‐3H]Kynurenine in the Rat Brain In Vivo: Evidence for the Existence of a Functional Kynurenine Pathway

Guidetti, P., Eastman, C. L., & Schwarcz, R. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65062621.x · Cited by 94

Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys

Grégoire, L., Rassoulpour, A., GUIDETTI, P., Samadi, P., BEDARD, P., Izzo, E., Schwarcz, R. M., & Paolo, T. D. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.007 · Cited by 91

Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

Erhardt, S., & Engberg, G. (2002) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2002.00962.x · Cited by 91

Nicotinylalanine Increases the Formation of Kynurenic Acid in the Brain and Antagonizes Convulsions

Russi, P., Alesiani, M., Lombardi, G., Davolio, P. L., Pellicciari, R., & Moroni, F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10097.x · Cited by 89

Effects of Kynurenine Pathway Inhibition on NAD+ Metabolism and Cell Viability in Human Primary Astrocytes and Neurons

Braidy, N., Guillemin, G., & Grant, R. (2011) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s7052 · Cited by 87

Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors

Fazio, F., Lionetto, L., Molinaro, G., Bertrand, H., Acher, F., Ngomba, R. T., Notartomaso, S., Curini, M., Rosati, O., Scarselli, P., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.074765 · Cited by 86

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84

Kynurenic Acid: A Potential Pathogen in Brain Disordersa

Schwarcz, R. M., Du, F., Schmidt, W., Turski, W. A., Gramsbergen, J. B., Okuno, E., & Roberts, R. C. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24532.x · Cited by 80

Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at α7* Nicotinic Receptors

Lopes, C., Pereira, E. F. R., Wu, H., Purushottamachar, P., Njar, V. C. O., Schwarcz, R. M., & Albuquerque, E. X. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123109 · Cited by 79

Modulators of the Kynurenine Pathway of Tryptophan Metabolism: Synthesis and Preliminary Biological Evaluation of ( S )‐4‐(Ethylsulfonyl)benzoylalanine, a Potent and Selective Kynurenine Aminotransferase II (KAT II) Inhibitor

Pellicciari, R., Rizzo, R. C., Costantino, G., Marinozzi, M., Amori, L., Guidetti, P., Wu, H., & Schwarcz, R. M. (2006) · ChemMedChem · doi:10.1002/cmdc.200500095 · Cited by 78

Tissue expression and biochemical characterization of human 2‐amino 3‐carboxymuconate 6‐semialdehyde decarboxylase, a key enzyme in tryptophan catabolism

Pucci, L., Perozzi, S., Cimadamore, F., Orsomando, G., & Raffaelli, N. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05635.x · Cited by 78

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues

Kohl, C. A., Walch, T., Huber, R., Kemmler, G., Neurauter, G., Fuchs, D., Sölder, E., Schröcksnadel, H., & Sperner‐Unterweger, B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.013 · Cited by 78

Heme: A Regulator of Rat Hepatic Tryptophan 2,3-Dioxygenase?

Ren, S., & Correia, M. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1755 · Cited by 76

Biochemical and Phenotypic Abnormalities in Kynurenine Aminotransferase II-Deficient Mice

Yü, P., Prospero, N. A. D., Sapko, M. T., Cai, T., Chen, A., Meléndez‐Ferro, M., Du, F., Whetsell, W. O., Guidetti, P., Schwarcz, R. M., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6919-6930.2004 · Cited by 76

Quinolinic Acid Phosphoribosyltransferase in Rat Brain

Foster, A. C., Zinkand, W. C., & Schwarcz, R. M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05435.x · Cited by 75

Presence of 3‐Hydroxyanthranilic Acid in Rat Tissues and Evidence for Its Production from Anthranilic Acid in the Brain

Baran, H., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04553.x · Cited by 74

Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3

Uwai, Y., Honjo, H., & Iwamoto, K. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.11.003 · Cited by 74

Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels

Mok, M. H. S., Fricker, A.-C., Weil, A., & Kew, J. N. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.003 · Cited by 74

Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus—infected rhesus macaques: Relationship to clinical and viral status

Heyes, M. P., Mefford, I. N., Quearry, B. J., Dedhia, M., & Lackner, A. A. (1990) · Annals of Neurology · doi:10.1002/ana.410270614 · Cited by 73

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72

Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway.

Dang, Y.-H., Dale, W. E., & Brown, O. R. (2000) · Free Radical Biology & Medicine · doi:10.1016/s0891-5849(99)00272-5 · Cited by 72

Xanthurenic acid distribution, transport, accumulation and release in the rat brain

Gobaille, S., Kemmel, V., Brumaru, D., Dugave, C., Aunis, D., & Maître, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05219.x · Cited by 72

Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons

Erhardt, S., Öberg, H., Mathé, J. M., & Engberg, G. (2001) · Amino Acids · doi:10.1007/s007260170032 · Cited by 69

Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

Rodgers, J., Stone, T. W., Barrett, M. P., Bradley, B., & Kennedy, P. G. E. (2009) · Brain · doi:10.1093/brain/awp074 · Cited by 69

Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: Up-regulation by inflammatory stimuli and with clinical infection

Manuelpillai, U., Ligam, P., Smythe, G. A., Wallace, E. M., Hirst, J. J., & Walker, D. W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.090 · Cited by 65

Ueber Kynurensäure

Liebig, J. (1853) · Justus Liebig s Annalen der Chemie · doi:10.1002/jlac.18530860115 · Cited by 65

Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity

Connick, J. H., Heywood, G. C., Sills, G. J., Thompson, G., Brodie, M. J., & Stone, T. W. (1992) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(92)90017-e · Cited by 61

Kynurenines as Probable Participants of Depression

Lapin, I. P. (1973) · Pharmacopsychiatry · doi:10.1055/s-0028-1094391 · Cited by 61

Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate

Hodgkins, P., & Schwarcz, R. M. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00208.x · Cited by 59

Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: Effect of aminooxyacetic acid

Speciale, C., Wu, H., Gramsbergen, J. B., Turski, W. A., Ungerstedt, U., & Schwarcz, R. M. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90410-b · Cited by 59

Indole-3-Pyruvic and -Propionic Acids, Kynurenic Acid, and Related Metabolites as Luminophores and Free-Radical Scavengers

Hardeland, R., Zsizsik, B. K., Pöeggeler, B., Fuhrberg, B., Holst, S., & Coto‐Montes, A. M. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_49 · Cited by 59

α-Methyl- L -Tryptophan: Mechanisms for Tracer Localization of Epileptogenic Brain Regions

Chugani, D. C. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.73 · Cited by 57

Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus

Copeland, C. S., Neale, S. A., & Salt, T. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.009 · Cited by 55

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis

Linderholm, K. R., Andersson, A., Olsson, S. K., Olsson, E., Snodgrass, R., Engberg, G., & Erhardt, S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.003 · Cited by 50

Metabolism of Tryptophan in Depressive Disease

Frazer, A. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200040070012 · Cited by 50

Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood

Akagbosu, C., Evans, G. C., Gulick, D., Suckow, R. F., & Bucci, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq151 · Cited by 50

Metabolism of 6-chlorotryptophan to 4-chloro-3-hydroxyanthranilic acid: A potent inhibitor of 3-hydroxyanthranilic acid oxidase

Parli, C. J., Krieter, P. A., & Schmidt, B. K. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90164-2 · Cited by 49

Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain

Wu, H., & Schwarcz, R. M. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02087-x · Cited by 47

Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population

Aoyama, N., Takahashi, N., Saito, S., Maeno, N., Ishihara, R., Ji, X., Miura, H., Ikeda, M., Suzuki, T., Kitajima, T., et al. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00231.x · Cited by 46

Modulation of the function of presynaptic α7 and non‐α7 nicotinic receptors by the tryptophan metabolites, 5‐hydroxyindole and kynurenate in mouse brain

Grilli, M., Raiteri, L., Patti, L., Parodi, M., Robino, F., Raiteri, M., & Marchi, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706914 · Cited by 43

Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats

Speciale, C., Ungerstedt, U., & Schwarcz, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90601-0 · Cited by 43

Organ Distribution of Rat Kynureninase and Changes of Its Activity during Development

Kawai, J., Okuno, E., & Kido, R. (2017) · Enzyme · doi:10.1159/000469117 · Cited by 43

Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain

Rassoulpour, A., Wu, H.-Q., Pöeggeler, B., & Schwarcz, R. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00577-0 · Cited by 42

Systemic administration of kainate induces marked increases of endogenous kynurenic acid in various brain regions and plasma of rats

Baran, H., Gramer, M., Hönack, D., & Löscher, W. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00443-o · Cited by 42

On the Production and Disposition of Quinolinic Acid in Rat Brain and Liver Slices

Speciale, C., & Schwarcz, R. M. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05840.x · Cited by 42

Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.

Chiarugi, A., & Moroni, F. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00048-9 · Cited by 40

Glial activation precedes seizures and hippocampal neurodegeneration in measles virus–infected mice

Lehrmann, E., Guidetti, P., Löve, A., Williamson, J., Bertram, E. H., & Schwarcz, R. M. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01489.x · Cited by 38

Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum

Lehrmann, E., Molinari, A., Speciale, C., & Schwarcz, R. (2001) · Experimental Brain Research · doi:10.1007/s002210100887 · Cited by 38

2‐Oxoacids Regulate Kynurenic Acid Production in the Rat Brain

Hodgkins, P., Wu, H., Zielke, R. H., & Schwarcz, R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720643.x · Cited by 36

Perinatal kynurenine 3‐hydroxylase inhibition in rodents: Pathophysiological implications

Ceresoli‐Borroni, G., Guidetti, P., Amori, L., Pellicciari, R., & Schwarcz, R. M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21183 · Cited by 34

ChemInform Abstract: Synthesis and Biochemical Evaluation of N‐(4‐Phenylthiazol‐2‐yl)benzenesulfonamides as High‐Affinity Inhibitors of Kynurenine 3‐Hydroxylase.

Roever, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1998) · ChemInform · doi:10.1002/chin.199820156 · Cited by 34

Ecni GC-MS Analysis of Picolinic and Quinolinic Acids and Their Amides in Human Plasma, CSF, and Brain Tissue

Smythe, G. A., Poljak, A., Bustamante, S., Braga, O., Maxwell, A., Grant, R., & Sachdev, P. S. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_83 · Cited by 33

Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury

Blight, A. R., Saito, K., & Heyes, M. P. (1993) · Brain Research · doi:10.1016/0006-8993(93)91167-q · Cited by 32

Impaired Dexamethasone-Mediated Induction of Tryptophan 2,3-Dioxygenase in Heme-Deficient Rat Hepatocytes: Translational Control by a Hepatic eIF2α Kinase, the Heme-Regulated Inhibitor

Liao, M., Pabarcus, M. K., Wang, Y., Hefner, C., Maltby, D., Medzihradszky, K., Salas-Castillo, S. P., Yan, J. S., Maher, J., & Correia, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124602 · Cited by 32

Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats

Batterman, K. V., & Bucci, D. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.014 · Cited by 30

2-Amino-4-[3′-hydroxyphenyl]-4-hydroxybutanoic acid; A potent inhibitor of rat and recombinant human kynureninase

Walsh, H. A., Leslie, P. L., O'Shea, K. C., & Botting, N. P. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00758-2 · Cited by 29

Neonatal Asphyxia in Rats: Acute Effects on Cerebral Kynurenine Metabolism

Ceresoli‐Borroni, G., & Schwarcz, R. M. (2001) · Pediatric Research · doi:10.1203/00006450-200108000-00011 · Cited by 28

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180

From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.

Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012

Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat

Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683

The Influence of Kynurenine Metabolites on Neurodegenerative Pathologies

Pathak, S., Nadar, R. M., Kim, S., Liu, K., Govindarajulu, M., Cook, P., Alexander, C. S. W., Dhanasekaran, M., & Moore, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020853 · Cited by 97

The kynurenine pathway of tryptophan degradation as a drug target

Schwarcz, R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.006 · Cited by 265

KYNURENINES IN PATHOGENESIS OF ENDOGENOUS PSYCHIATRIC DISORDERS

Shilov, Y., & Mv, B. (2013) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v68i1.535 · Cited by 12

The kynurenine pathway and neurodegenerative disease

Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309

Kynurenines in the CNS: recent advances and new questions

Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641